2003
DOI: 10.1016/s0936-6555(03)00162-6
|View full text |Cite
|
Sign up to set email alerts
|

External Beam Radiotherapy in the Management of Differentiated Thyroid Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
25
0
2

Year Published

2006
2006
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 73 publications
(28 citation statements)
references
References 7 publications
1
25
0
2
Order By: Relevance
“…In 2003, Ford et al reported that local recurrence and OS are related to the dose prescribed, based on a small cohort (n = 41), suggesting a dose of a least 50 Gy is needed to impact local control and possibly survival. 49 Our findings concur with the recent management guidelines put forth by the American Thyroid Association Guidelines Taskforce, which considers EBR only for patients with gross residual tumors and in whom further surgery or RIA treatment are likely to be ineffective. 42 According to the relative radioresistance and slow regression rate of PTC, Tuttle et al reported no apparent advantage of EBR for OS, but significant morbidities.…”
Section: External Beam Radiation Therapy (Ebr)supporting
confidence: 88%
“…In 2003, Ford et al reported that local recurrence and OS are related to the dose prescribed, based on a small cohort (n = 41), suggesting a dose of a least 50 Gy is needed to impact local control and possibly survival. 49 Our findings concur with the recent management guidelines put forth by the American Thyroid Association Guidelines Taskforce, which considers EBR only for patients with gross residual tumors and in whom further surgery or RIA treatment are likely to be ineffective. 42 According to the relative radioresistance and slow regression rate of PTC, Tuttle et al reported no apparent advantage of EBR for OS, but significant morbidities.…”
Section: External Beam Radiation Therapy (Ebr)supporting
confidence: 88%
“…It is indicated as initial treatment or for recurrence of unresectable tumors or local invasion presumed to have macro-or microscopic residual disease, which does not concentrate 131 I. External beam radiotherapy may also be indicated for bone or brain metastases (110,111).…”
Section: Role Of External Beam Radiotherapymentioning
confidence: 99%
“…External beam irradiation is used infrequently in the management of thyroid cancer except as a palliative treatment for locally advanced, otherwise unresectable disease (171). There are reports of responses among patients with locally advanced disease (172,173), and improved relapse-free and cause-specific survival (174). It remains unknown whether external beam radiation might reduce the risk for recurrence in the neck after adequate primary surgery and/or radioiodine treatment.…”
Section: Is There a Role For Adjunctive External Beam Irradiation Or mentioning
confidence: 99%